Britannia Life Sciences Inc.

DB:L020 Stock Report

Market Cap: €9.2m

Britannia Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of L020?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,503,1220.926%
Individual Insiders60,373,78137.2%
General Public100,377,43661.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 4 shareholders own 38.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.3%
Peter Shippen
37,753,231€2.1m1.89%no data
11.5%
Mark Bowes-Cavanagh
18,600,000€1.1m0%no data
2.48%
Scott Secord
4,020,550€228.6k0%no data
0.93%
Purpose Investments Inc.
1,503,122€85.5k0%no data